Literature DB >> 2580626

Two distinct tumor cell growth-inhibiting factors from a human rhabdomyosarcoma cell line.

C M Fryling, K K Iwata, P A Johnson, W B Knott, G J Todaro.   

Abstract

Tumor cell growth-inhibiting factors (TIFs) have been shown to inhibit the growth of tumor cell lines in culture. TIF-1, the first TIF to be described, is a low-molecular-weight, acid- and heat-stable polypeptide with no antiviral activity. A second class of TIFs (TIF-2) has now been isolated from the conditioned media of a human rhabdomyosarcoma cell line and partially purified by polyacrylamide gel filtration, cation exchange, and reverse-phase high-pressure liquid chromatography. Partially purified preparations of TIF-2 inhibit the growth of a variety of human tumor cells in soft agar and monolayer cultures and are mitogenic for normal human and mouse cells. TIF-2 has no antiviral activity. The growth-inhibitory effects of TIF-2 are reversible when the affected cells are no longer exposed to the factor. Although both TIF-1 and TIF-2 are obtained from the same source, they can be distinguished by their molecular weight, heat lability, elution pattern from reverse-phase high-pressure liquid chromatography, and their effect on the growth of mink lung epithelial cells. The growth of a human tumor cell variant, selected for resistance to growth inhibition by TIF-1, is inhibited by TIF-2. TIFs may therefore be a family of related polypeptides which selectively inhibit the growth of tumor cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2580626

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

1.  Epithelins 1 and 2: isolation and characterization of two cysteine-rich growth-modulating proteins.

Authors:  M Shoyab; V L McDonald; C Byles; G J Todaro; G D Plowman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

2.  Growth suppression of transformed cells by a human placental extract not related to transforming growth factor beta.

Authors:  J L Klein; E Hamel; J L Tayot; H Yamasaki
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

3.  Growth modulation of human tumor cells by a growth-inhibiting activity derived from tumorigenic V79 Chinese hamster cells.

Authors:  I Ichinose; S Nakano; T Esaki; T Koga; K Mitsugi; H Yamada; Y Niho
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-04       Impact factor: 2.416

4.  An activated form of transforming growth factor beta is produced by cocultures of endothelial cells and pericytes.

Authors:  A Antonelli-Orlidge; K B Saunders; S R Smith; P A D'Amore
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

5.  Inhibition of epidermal growth factor-induced cellular proliferation.

Authors:  D S Strayer; J L Leibowitz
Journal:  Am J Pathol       Date:  1987-08       Impact factor: 4.307

6.  Oncostatin M: a growth regulator produced by differentiated histiocytic lymphoma cells.

Authors:  J M Zarling; M Shoyab; H Marquardt; M B Hanson; M N Lioubin; G J Todaro
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

7.  Amphiregulin: a bifunctional growth-modulating glycoprotein produced by the phorbol 12-myristate 13-acetate-treated human breast adenocarcinoma cell line MCF-7.

Authors:  M Shoyab; V L McDonald; J G Bradley; G J Todaro
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

8.  Physical and biological characterization of a growth-inhibitory activity purified from the neuroepithelioma cell line A673.

Authors:  K Stam; A A Stewart; G Y Qu; K K Iwata; D Fenyö; B T Chait; D R Marshak; J D Haley
Journal:  Biochem J       Date:  1995-01-01       Impact factor: 3.857

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.